Efficacy and safety of osilodrostat in patients with Cushings disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
暂无分享,去创建一个
X. Bertagna | M. Fleseriu | R. Leelawattana | J. Newell-Price | A. Shimatsu | A. Lacroix | J. Findling | Kim Jh | R. Pivonello | L. Tauchmanovà | F. Gu | A. Laplanche | Lee Ej | P. O'Connell | Auchus Rj | Pedroncelli Am | Biller Bmk